Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial
- Submitting institution
-
University College London
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 11561
- Type
- D - Journal article
- DOI
-
10.1016/S2352-3026(20)30100-9
- Title of journal
- The Lancet Haematology
- Article number
- -
- First page
- E469
- Volume
- 7
- Issue
- 6
- ISSN
- 2352-3026
- Open access status
- Technical exception
- Month of publication
- May
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
https://ars.els-cdn.com/content/image/1-s2.0-S2352302620301009-mmc1.pdf
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
25
- Research group(s)
-
-
- Citation count
- 2
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to: A.(i) the conception and design of the study B (ii) critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -